Use access key #2 to skip to page content.
$78.19 -2.43 (-3.01%)
10/7/2008 4:00 PM

Genentech, Inc. (DNA)

CAPS Rating:
*****

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

View All Commentary (DNA)

Recs

4

Avatar xthecritic (37.99) Submitted: 2/07/08 1:36 PM : Outperform Start Price: $71.33 DNA Score: 21.58

Genentech is the #1 biotech company in the world. The company is currently trading near its 52 week low and at a 25x PE multiple with a strong growth profile. This is a great opportunity to get into DNA at a nice valuation. Healthcare companies will continue to outperform in this chopping economic environment. This is a no-brainer outperform.

Inject your portfolio with DNA.

-- Prophet of Portsmouth

Report this Post Replies: 0 | Reply

Featured Broker Partners